table of content
1 Study Coverage
1.1 Parkinson's Disease (PD) Drugs Product Introduction
1.2 Global Parkinson's Disease (PD) Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Parkinson's Disease (PD) Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume for the Year 2017-2028
1.3 United States Parkinson's Disease (PD) Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Parkinson's Disease (PD) Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Parkinson's Disease (PD) Drugs Sales in Volume for the Year 2017-2028
1.4 Parkinson's Disease (PD) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Parkinson's Disease (PD) Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Parkinson's Disease (PD) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Parkinson's Disease (PD) Drugs Market Dynamics
1.5.1 Parkinson's Disease (PD) Drugs Industry Trends
1.5.2 Parkinson's Disease (PD) Drugs Market Drivers
1.5.3 Parkinson's Disease (PD) Drugs Market Challenges
1.5.4 Parkinson's Disease (PD) Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Parkinson's Disease (PD) Drugs Market Segment by Type
2.1.1 Dopamine Agonist
2.1.2 Monoamine Oxidase Inhibitors
2.1.3 Acetylcholinesterase Inhibitors
2.1.4 Glutamate Inhibitors
2.2 Global Parkinson's Disease (PD) Drugs Market Size by Type
2.2.1 Global Parkinson's Disease (PD) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Parkinson's Disease (PD) Drugs Market Size by Type
2.3.1 United States Parkinson's Disease (PD) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Parkinson's Disease (PD) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Parkinson's Disease (PD) Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Family
3.2 Global Parkinson's Disease (PD) Drugs Market Size by Application
3.2.1 Global Parkinson's Disease (PD) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Parkinson's Disease (PD) Drugs Market Size by Application
3.3.1 United States Parkinson's Disease (PD) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Parkinson's Disease (PD) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Parkinson's Disease (PD) Drugs Competitor Landscape by Company
4.1 Global Parkinson's Disease (PD) Drugs Market Size by Company
4.1.1 Top Global Parkinson's Disease (PD) Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Parkinson's Disease (PD) Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Parkinson's Disease (PD) Drugs Price by Manufacturer (2017-2022)
4.2 Global Parkinson's Disease (PD) Drugs Concentration Ratio (CR)
4.2.1 Parkinson's Disease (PD) Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Parkinson's Disease (PD) Drugs in 2021
4.2.3 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Parkinson's Disease (PD) Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Parkinson's Disease (PD) Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Parkinson's Disease (PD) Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Parkinson's Disease (PD) Drugs Market Size by Company
4.5.1 Top Parkinson's Disease (PD) Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Parkinson's Disease (PD) Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Parkinson's Disease (PD) Drugs Sales by Players (2020, 2021 & 2022)
5 Global Parkinson's Disease (PD) Drugs Market Size by Region
5.1 Global Parkinson's Disease (PD) Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Parkinson's Disease (PD) Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Parkinson's Disease (PD) Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Parkinson's Disease (PD) Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Parkinson's Disease (PD) Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Parkinson's Disease (PD) Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Parkinson's Disease (PD) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporation Information
7.1.2 Boehringer Ingelheim Description and Business Overview
7.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
7.1.5 Boehringer Ingelheim Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporation Information
7.2.2 GlaxoSmithKline Description and Business Overview
7.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products Offered
7.2.5 GlaxoSmithKline Recent Development
7.3 Novartis
7.3.1 Novartis Corporation Information
7.3.2 Novartis Description and Business Overview
7.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novartis Parkinson's Disease (PD) Drugs Products Offered
7.3.5 Novartis Recent Development
7.4 Teva Pharmaceutical Industries
7.4.1 Teva Pharmaceutical Industries Corporation Information
7.4.2 Teva Pharmaceutical Industries Description and Business Overview
7.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products Offered
7.4.5 Teva Pharmaceutical Industries Recent Development
7.5 AbbVie
7.5.1 AbbVie Corporation Information
7.5.2 AbbVie Description and Business Overview
7.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 AbbVie Parkinson's Disease (PD) Drugs Products Offered
7.5.5 AbbVie Recent Development
7.6 Abital Pharma
7.6.1 Abital Pharma Corporation Information
7.6.2 Abital Pharma Description and Business Overview
7.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products Offered
7.6.5 Abital Pharma Recent Development
7.7 Addex Therapeutics
7.7.1 Addex Therapeutics Corporation Information
7.7.2 Addex Therapeutics Description and Business Overview
7.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products Offered
7.7.5 Addex Therapeutics Recent Development
7.8 Biogen
7.8.1 Biogen Corporation Information
7.8.2 Biogen Description and Business Overview
7.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Biogen Parkinson's Disease (PD) Drugs Products Offered
7.8.5 Biogen Recent Development
7.9 Eisai
7.9.1 Eisai Corporation Information
7.9.2 Eisai Description and Business Overview
7.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Eisai Parkinson's Disease (PD) Drugs Products Offered
7.9.5 Eisai Recent Development
7.10 Eli Lilly
7.10.1 Eli Lilly Corporation Information
7.10.2 Eli Lilly Description and Business Overview
7.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products Offered
7.10.5 Eli Lilly Recent Development
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Corporation Information
7.11.2 F. Hoffmann-La Roche Description and Business Overview
7.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Products Offered
7.11.5 F. Hoffmann-La Roche Recent Development
7.12 H. Lundbeck
7.12.1 H. Lundbeck Corporation Information
7.12.2 H. Lundbeck Description and Business Overview
7.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 H. Lundbeck Products Offered
7.12.5 H. Lundbeck Recent Development
7.13 Impax Laboratories
7.13.1 Impax Laboratories Corporation Information
7.13.2 Impax Laboratories Description and Business Overview
7.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Impax Laboratories Products Offered
7.13.5 Impax Laboratories Recent Development
7.14 Kyowa Hakko Kirin
7.14.1 Kyowa Hakko Kirin Corporation Information
7.14.2 Kyowa Hakko Kirin Description and Business Overview
7.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Kyowa Hakko Kirin Products Offered
7.14.5 Kyowa Hakko Kirin Recent Development
7.15 Otsuka Pharmaceutical
7.15.1 Otsuka Pharmaceutical Corporation Information
7.15.2 Otsuka Pharmaceutical Description and Business Overview
7.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Otsuka Pharmaceutical Products Offered
7.15.5 Otsuka Pharmaceutical Recent Development
7.16 Pfizer
7.16.1 Pfizer Corporation Information
7.16.2 Pfizer Description and Business Overview
7.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Pfizer Products Offered
7.16.5 Pfizer Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
8.2 Parkinson's Disease (PD) Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Parkinson's Disease (PD) Drugs Distributors
8.3 Parkinson's Disease (PD) Drugs Production Mode & Process
8.4 Parkinson's Disease (PD) Drugs Sales and Marketing
8.4.1 Parkinson's Disease (PD) Drugs Sales Channels
8.4.2 Parkinson's Disease (PD) Drugs Distributors
8.5 Parkinson's Disease (PD) Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
